Lose weight when diet and exercise alone stop working
Why this is harder than it should be
You have counted calories. You have tried intermittent fasting. You have done the workout programs. And maybe they worked for a while -- but the weight came back, or the last 20-30 pounds refuse to move no matter what you do.
The issue is not discipline. When your body's hunger hormones are dysregulated, willpower is fighting biology. GLP-1 and GIP receptors control appetite signaling in your brain. When those signals misfire, you feel hungry even when your body has plenty of fuel. No amount of meal prep fixes a broken signal.
Modern peptide therapy targets the root cause -- the hormonal signaling -- not the symptom.
Compounds that address weight loss
Each compound is prescribed by a licensed provider and shipped from a US pharmacy.
What the research says
Tirzepatide produced 22.5% average body weight loss in the SURMOUNT-1 trial (n=2,539). In the SURMOUNT-5 head-to-head trial against semaglutide, tirzepatide delivered 47% more weight loss over 72 weeks. Participants lost an average of 20.2% of body weight on tirzepatide vs 13.7% on semaglutide. Both trials were published in the New England Journal of Medicine.
Frequently asked questions
How much weight can I realistically lose with peptide therapy?
In the SURMOUNT-1 trial, average weight loss with tirzepatide was 22.5% of body weight over 72 weeks. For a 220 lb person, that is roughly 50 lbs. Individual results vary based on starting weight, dose, diet, and activity level. Most people see meaningful results (10-15 lbs) within the first 3 months.
Is peptide-based weight loss safe?
Tirzepatide has been studied in trials involving over 10,000 participants and is FDA-approved for both type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). Common side effects are gastrointestinal (nausea, diarrhea) and typically resolve as your body adjusts. All LYV protocols are prescribed by licensed physicians who monitor your progress.
Will I gain the weight back if I stop?
Weight regain after stopping GLP-1 therapy is common if no other changes are made. The most successful approach combines peptide therapy with gradual habit changes -- better nutrition, consistent exercise, improved sleep. Many patients use a higher dose for the initial weight loss phase, then transition to a lower maintenance dose long-term.
How is this different from Ozempic or Wegovy?
Ozempic and Wegovy contain semaglutide, which targets GLP-1 receptors only. Tirzepatide targets both GLP-1 and GIP receptors, producing significantly more weight loss in head-to-head trials. LYV prescribes compounded tirzepatide in pre-dosed pens -- same active compound, delivered from a licensed US pharmacy at a fraction of the brand-name cost.
Do I still need to diet and exercise?
Peptide therapy works best alongside a healthy diet and regular movement -- that was the protocol in the clinical trials. The difference is that tirzepatide makes both dramatically easier. Appetite decreases naturally, portions self-regulate, and the constant food noise quiets down. Most patients report that eating well stops feeling like a fight.
Ready to take action on weight loss?
Take a 2-minute quiz. Get matched to a personalized protocol.